REQUEST A DEMO
Total
USD $0.00
Search more companies

Fitwel Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Fitwel Pharmaceuticals Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Fitwel Pharmaceuticals Private Limited is an unlisted company, incorporated on 15/07/2014. It has its registered office in the State of Maharashtra, India. Company's corporate identification number (CIN) is U24233MH2014PTC256071 and registration number is 256071. The company is a trade company, it is engaged in wholesale trading.

Legal Address
Jems Apt 12 1St Floor, Manoj Ind Est, Plot No 40A G.D. Ambekar Marg, Wadala
Mumbai; Maharashtra; Postal Code: 400031

Contact Details: Purchase the Fitwel Pharmaceuticals Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Fitwel Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Fitwel Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
July 15, 2014
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Fitwel Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-17.35%
Total operating revenue
-17.24%
Operating profit (EBIT)
108.97%
EBITDA
46.9%
Net Profit (Loss) for the Period
128.77%
Total assets
-0.46%
Total equity
48.7%
Operating Profit Margin (ROS)
1.82%
Net Profit Margin
1.92%
Return on Equity (ROE)
16.58%
Debt to Equity Ratio
-193.32%
Quick Ratio
0.28%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?